119 related articles for article (PubMed ID: 6712177)
1. Interaction of cyclophosphamide with DNA in isolated rat liver cell nuclei.
Lindemann H
Anticancer Res; 1984; 4(1-2):53-8. PubMed ID: 6712177
[TBL] [Abstract][Full Text] [Related]
2. Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.
Hemminki K
Cancer Res; 1985 Sep; 45(9):4237-43. PubMed ID: 4028012
[TBL] [Abstract][Full Text] [Related]
3. Conversion of 4-hydroperoxycyclophosphamide and 4-hydroxycyclophosphamide to phosphoramide mustard and acrolein mediated by bifunctional catalysis.
Low JE; Borch RF; Sladek NE
Cancer Res; 1982 Mar; 42(3):830-7. PubMed ID: 7059981
[TBL] [Abstract][Full Text] [Related]
4. Investigation on cyclophosphamide treatment during the preimplantation period. II. In vitro studies on the effects of cyclophosphamide and its metabolites 4-OH-cyclophosphamide, phosphoramide mustard, and acrolein on blastulation of four-cell and eight-cell mouse embryos and on their subsequent development during implantation.
Spielmann H; Jacob-Müller U
Teratology; 1981 Feb; 23(1):7-13. PubMed ID: 7245091
[TBL] [Abstract][Full Text] [Related]
5. A cyclophosphamide/DNA phosphoester adduct formed in vitro and in vivo.
Maccubbin AE; Caballes L; Riordan JM; Huang DH; Gurtoo HL
Cancer Res; 1991 Feb; 51(3):886-92. PubMed ID: 1988129
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity, DNA cross-linking, and single strand breaks induced by activated cyclophosphamide and acrolein in human leukemia cells.
Crook TR; Souhami RL; McLean AE
Cancer Res; 1986 Oct; 46(10):5029-34. PubMed ID: 3463409
[TBL] [Abstract][Full Text] [Related]
7. Cyclophosphamide modulates rat hepatic cytochrome P450 2C11 and steroid 5 alpha-reductase activity and messenger RNA levels through the combined action of acrolein and phosphoramide mustard.
Chang TK; Waxman DJ
Cancer Res; 1993 Jun; 53(11):2490-7. PubMed ID: 8495410
[TBL] [Abstract][Full Text] [Related]
8. Involvement of human glutathione S-transferase isoenzymes in the conjugation of cyclophosphamide metabolites with glutathione.
Dirven HA; van Ommen B; van Bladeren PJ
Cancer Res; 1994 Dec; 54(23):6215-20. PubMed ID: 7954469
[TBL] [Abstract][Full Text] [Related]
9. Cross-linking of DNA in L1210 cells and nuclei treated with cyclophosphamide and phosphoramide mustard.
Surya YA; Rosenfeld JM; Hillcoat BL
Cancer Treat Rep; 1978 Jan; 62(1):23-9. PubMed ID: 564237
[TBL] [Abstract][Full Text] [Related]
10. [Methylation and degradation of chromatin DNA in isolated rat liver cell nuclei].
Khodarev NN; Votrin II; Sokolov NN; Basnak'ian AG
Biokhimiia; 1979 Jun; 44(6):1058-67. PubMed ID: 465603
[TBL] [Abstract][Full Text] [Related]
11. Steroidal drug cyproterone acetate is activated to DNA-binding metabolites by sulfonation.
Werner S; Kunz S; Wolff T; Schwarz LR
Cancer Res; 1996 Oct; 56(19):4391-7. PubMed ID: 8813132
[TBL] [Abstract][Full Text] [Related]
12. Blood levels of alkylating metabolites of cyclophosphamide in the mouse after iv or oral administration.
Struck RF; Alberts DS
Cancer Treat Rep; 1984 May; 68(5):765-70. PubMed ID: 6722832
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxicity and DNA cross-linking activity of 4-sulfidocyclophosphamides in mouse leukemia cells in vitro.
Erickson LC; Ramonas LM; Zaharko DS; Kohn KW
Cancer Res; 1980 Nov; 40(11):4216-20. PubMed ID: 7471062
[TBL] [Abstract][Full Text] [Related]
14. Enzymatic activation and binding of adriamycin to nuclear DNA.
Sinha BK; Trush MA; Kennedy KA; Mimnaugh EG
Cancer Res; 1984 Jul; 44(7):2892-6. PubMed ID: 6327028
[TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome P450 in oxazaphosphorine metabolism. Deactivation via N-dechloroethylation and activation via 4-hydroxylation catalyzed by distinct subsets of rat liver cytochromes P450.
Yu L; Waxman DJ
Drug Metab Dispos; 1996 Nov; 24(11):1254-62. PubMed ID: 8937861
[TBL] [Abstract][Full Text] [Related]
16. Depurinating and stable benzo[a]pyrene-DNA adducts formed in isolated rat liver nuclei.
Devanesan PD; Higginbotham S; Ariese F; Jankowiak R; Suh M; Small GJ; Cavalieri EL; Rogan EG
Chem Res Toxicol; 1996; 9(7):1113-6. PubMed ID: 8902265
[TBL] [Abstract][Full Text] [Related]
17. Trapping of DNA-reactive metabolites of therapeutic or carcinogenic agents by carbon-14-labeled synthetic polynucleotides.
Mehta JR; Ludlum DB
Cancer Res; 1982 Aug; 42(8):2996-9. PubMed ID: 7093949
[TBL] [Abstract][Full Text] [Related]
18. In vivo modulation of alternative pathways of P-450-catalyzed cyclophosphamide metabolism: impact on pharmacokinetics and antitumor activity.
Yu LJ; Drewes P; Gustafsson K; Brain EG; Hecht JE; Waxman DJ
J Pharmacol Exp Ther; 1999 Mar; 288(3):928-37. PubMed ID: 10027828
[TBL] [Abstract][Full Text] [Related]
19. Half-life of oxazaphosphorines in biological fluids.
Sladek NE; Powers JF; Grage GM
Drug Metab Dispos; 1984; 12(5):553-9. PubMed ID: 6149904
[TBL] [Abstract][Full Text] [Related]
20. Nature of the binding of activated cyclophosphamide to calf thymus DNA and pBR-322 plasmid DNA.
Bansal SK; Love JH; Faletto MB; Gurtoo HL; Struck RF
Cancer Biochem Biophys; 1986 Jul; 8(3):193-202. PubMed ID: 3742481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]